Interaction of Moxifloxacin
Drug Interaction, Method development by HPLC, Complexation, Organic synthesis, Antimicrobial and Enzymatic Activities
(Sprache: Englisch)
Moxifloxacin is a fourth generation fluoroquinolone has potent activity against Gram-positive bacteria, especially against pneumococcus and anaerobes, and still retain excellent activity against aerobic Gram-negative pathogens. I developed different methods...
Leider schon ausverkauft
versandkostenfrei
Buch
79.00 €
39 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Interaction of Moxifloxacin “
Klappentext zu „Interaction of Moxifloxacin “
Moxifloxacin is a fourth generation fluoroquinolone has potent activity against Gram-positive bacteria, especially against pneumococcus and anaerobes, and still retain excellent activity against aerobic Gram-negative pathogens. I developed different methods for simultaneous determination of quinolones with different interacting drugs and performed drug-drug and drug-metals interactions by using these methods. We have synthesized derivatives and metal complexes of quinolones and characterized by physicochemical and spectroscopic methods (FT-IR, 1HNMR and mass spectrometry). The in-vitro antibacterial and antifungal activities of resulting complexes and derivatives were also performed and compared with the parent drug. Enzymatic activities of all synthesized compounds were carried out against different enzymes including urease, carbonic anhydrase, and -chymotrypsin.
Bibliographische Angaben
- Autor: Mahwish Akhtar
- 2012, Aufl., 388 Seiten, Maße: 15 x 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 3847333526
- ISBN-13: 9783847333524
Sprache:
Englisch
Kommentar zu "Interaction of Moxifloxacin"
0 Gebrauchte Artikel zu „Interaction of Moxifloxacin“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Interaction of Moxifloxacin".
Kommentar verfassen